Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Development of a vaccine against human immunodeficiency virus type 1 (HIV-1) is the main hope for controlling the acquired immunodeficiency syndrome pandemic. An ideal HIV vaccine should induce neutralizing antibodies, CD4+ helper T cells, and CD8+ cytotoxic T cells. While the induction of broadly neutralizing antibodies remains a highly challenging goal, there are a number of technologies capable of inducing potent cell-mediated responses in animal models, which are now starting to be tested in humans. Naked DNA immunization is one of them. This review focuses on the stimulation of HIV-specific T cells and discusses in the context of the current 'state-of-art' of DNA vaccines, the areas where this technology might assist either alone or as a part of more complex vaccine formulations in the HIV vaccine development.

Original publication

DOI

10.1111/j.0105-2896.2004.00151.x

Type

Journal article

Journal

Immunol Rev

Publication Date

06/2004

Volume

199

Pages

144 - 155

Keywords

AIDS Vaccines, Acquired Immunodeficiency Syndrome, Antigen Presentation, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, CpG Islands, HIV-1, Humans, Plasmids, Vaccines, DNA